Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Photobiomodul Photomed Laser Surg ; 42(2): 182-185, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38301213

RESUMO

Objective: To investigate the efficacy of Photobiomodulation therapy (PBMT) for the treatment of solitary rectal ulcer syndrome (SRUS). Background: SRUS is a benign disease, diagnosed by symptoms, clinical, and histological findings. PBMT has been reported for the treatment of various inflammation-based diseases including aphthous ulcer, but still no such study on the treatment of SRUS is published. Materials and methods: A 29-year Asian women, diagnosed for SRUS of 0.57 cm diameter, was treated by a laser at 635 nm through seven sessions. Laser fluence of 85 J/cm2 was delivered to ulcer lesion during each session for 10 min. Clinical results were valued by physician with sigmoid probe throughout PBMT sessions and no medicines were prescribed to the patient. Results: After seven sessions, the lesion was completely healed with 100% clinical response. In follow-up, patient did not respond to any additional/recurring abnormality, and no side effects were observed. Conclusions: In conclusion, PBMT by using laser at 635 nm is an effective treatment for SRUS without any side effects and patient remained comfortable throughout treatment sessions. Patient registration No. H-744/23.


Assuntos
Terapia com Luz de Baixa Intensidade , Doenças Retais , Feminino , Humanos , Doenças Retais/terapia , Doenças Retais/diagnóstico , Doenças Retais/patologia , Síndrome , Resultado do Tratamento , Úlcera/radioterapia , Úlcera/diagnóstico , Adulto
2.
Lasers Med Sci ; 33(3): 603-607, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29368069

RESUMO

Skin graft is a standard therapeutic technique in patients with deep ulcers, but managing donor site after grafting is very important. Although several modern dressings are available to enhance the comfort of donor site, using techniques that accelerate wound healing may enhance patient satisfaction. Low-level laser therapy (LLLT) has been used in several medical fields, including healing of diabetic, surgical, and pressure ulcers, but there is not any report of using this method for healing of donor site in burn patients. The protocols and informed consent were reviewed according to Medical Ethics Board of Shahid Beheshti University of Medical Sciences (IR.SBMU.REC.1394.363) and Iranian Registry of Clinical Trials (IRCT2016020226069N2). Eighteen donor sites in 11 patients with grade 3 burn ulcer were selected. Donor areas were divided into 2 parts, for laser irradiation and control randomly. Laser area was irradiated by a red, 655-nm laser light, 150 mW, 2 J/cm2, on days 0 (immediately after surgery), 3, 5, and 7. Dressing and other therapeutic care for both sites were the same. The patients and the person who analyzed the results were blinded. The size of donor site reduced in both groups during the 7-day study period (P < 0.01) and this reduction was significantly greater in the laser group (P = 0.01). In the present study, for the first time, we evaluate the effects of LLLT on the healing process of donor site in burn patients. The results showed that local irradiation of red laser accelerates wound healing process significantly.


Assuntos
Queimaduras/radioterapia , Queimaduras/cirurgia , Terapia com Luz de Baixa Intensidade/métodos , Transplante de Pele , Úlcera/radioterapia , Úlcera/cirurgia , Cicatrização/efeitos da radiação , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Irã (Geográfico) , Masculino , Doadores de Tecidos
3.
Med Clin North Am ; 97(5): 835-45, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23992895

RESUMO

Most of what we know today for interventional techniques for revascularization in patients with DF disease is derived from our knowledge on CLI in patients with PAD. There are today no dedicated randomized controlled trials on interventional treatment of DF. It is, however, clear that huge progress in interventional techniques has been obtained during the past decade. In most institutions, the nonsurgical option is the current first choice. As the aim of treatment is ulcer healing through temporary increase in blood flow, it is still unclear what the contribution of new stent and drug-eluting technologies will have on the clinical outcome of DF treatment. Long-term follow-up studies, dedicated to patients with an arterial DF problem, have to be performed before we can evaluate all these new technologies.


Assuntos
Pé Diabético/radioterapia , Extremidade Inferior/irrigação sanguínea , Radiografia Intervencionista/métodos , Índice de Gravidade de Doença , Úlcera/radioterapia , Pé Diabético/sangue , Humanos , Doses de Radiação , Radiologia Intervencionista , Gestão da Qualidade Total , Procedimentos Cirúrgicos Vasculares/métodos
4.
Int J Cancer ; 96(5): 297-304, 2001 Oct 20.
Artigo em Inglês | MEDLINE | ID: mdl-11582582

RESUMO

To study the effects of preoperative radiochemotherapy (RCT) on the healing of colonic anastomosis, the rectosigmoid colon in male Wistar rats was irradiated up to an end dose of 41.6 Gy (RT) or sham-irradiated (SR). During the last 5 days of the irradiation schedule, 5-fluorouracil (5-FU) was administered intraperitoneally in either a high dose (20 mg/kg, chemotherapy-high dose [CH]) or a low dose (10 mg/kg, chemotherapy-low dose [CL]). Animals were randomly arranged into six groups: group I, control (SR + saline intraperitoneally); group II, RT only; group III, SR + CL; group IV, RT + CL; group V, SR + CH; group VI, RT + CH. Four days after RCT, a side-to-side anastomosis was constructed between the irradiated rectosigmoid and the nonirradiated caecum. Animals were killed 10 days postoperatively. No significant differences were found in the anastomotic bursting pressure or the bursting wall tension. In group VI, mitoses were less (P < 0.01) and mucosal ulceration was more (P = 0.03) pronounced compared to group I. Sclerotic arteries were seen in all irradiated groups and in animals that received high-dose 5-FU alone. 5-FU administration in high or low dose, with or without RT, induced more inflammation in the submucosa compared to controls (P < 0.05). Conclusively, RCT has no detrimental effect on the mechanical strength of colonic anastomosis in this rat model. However, RCT with high-dose 5-FU induces more histological alterations at the anastomotic site.


Assuntos
Anastomose Cirúrgica , Antimetabólitos Antineoplásicos/uso terapêutico , Doenças do Colo/tratamento farmacológico , Doenças do Colo/radioterapia , Doenças do Colo/cirurgia , Fluoruracila/uso terapêutico , Cicatrização/efeitos dos fármacos , Cicatrização/efeitos da radiação , Animais , Peso Corporal/efeitos dos fármacos , Colo/patologia , Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/radioterapia , Neoplasias Colorretais/cirurgia , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Inflamação , Masculino , Mitose , Ratos , Ratos Wistar , Fatores de Tempo , Úlcera/tratamento farmacológico , Úlcera/radioterapia , Úlcera/cirurgia
5.
J Photochem Photobiol B ; 59(1-3): 1-8, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11332876

RESUMO

BACKGROUND AND OBJECTIVE: Ionizing radiation therapy by way of various beams such as electron, photon and neutron is an established method in tumor treatment. The side effects caused by this treatment such as ulcer, painful mastitis and delay of wound healing are well known, too. Biomodulation by low level laser therapy (LLLT) has become popular as a therapeutic modality for the acceleration of wound healing and the treatment of inflammation. Evidence for this kind of application, however, is not fully understood yet. This study intends to demonstrate the response of biomodulative laser treatment on the side effects caused by ionizing radiation by means of magnetic resonance imaging (MRI). STUDY DESIGN/PATIENTS AND METHODS: Six female patients suffering from painful mastitis after breast ionizing irradiation and one man suffering from radiogenic ulcer were treated with lambda=780 nm diode laser irradiation at a fluence rate of 5 J/cm2. LLLT was performed for a period of 4-6 weeks (mean sessions: 25 per patient, range 19-35). The tissue response was determined by means of MRI after laser treatment in comparison to MRI prior to the beginning of the LLLT. RESULTS: All patients showed complete clinical remission. The time-dependent contrast enhancement curve obtained by the evaluation of MR images demonstrated a significant decrease of enhancement features typical for inflammation in the affected area. CONCLUSION: Biomodulation by LLLT seems to be a promising treatment modality for side effects induced by ionizing radiation.


Assuntos
Neoplasias da Mama/complicações , Terapia a Laser , Mastite/radioterapia , Neoplasias Orofaríngeas/complicações , Úlcera/radioterapia , Adulto , Idoso , Neoplasias da Mama/imunologia , Neoplasias da Mama/radioterapia , Neoplasias da Mama/cirurgia , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Neoplasias Orofaríngeas/radioterapia , Neoplasias Orofaríngeas/cirurgia , Radiação Ionizante , Radioterapia Adjuvante/efeitos adversos
6.
G Chir ; 18(1-2): 31-5, 1997.
Artigo em Italiano | MEDLINE | ID: mdl-9206478

RESUMO

The authors analyze the most current methods for the treatment of ulcerated breast cancer in the elderly. They describe a peculiar case recently observed, characterized by an ulcerative lesion spreading from the hemiclavicle to the foreaxilla including the axillary cavity, causing a large phlebo-lymphaedema, anaesthesia and paresis of the homoteral upper limb. After an initial treatment with tamoxifen a scapulo-humeral disarticulation and a suture of the cutaneous wide defect were performed using a myo-skin graft which included the deltoid muscle. A radiotherapeutic treatment followed by tamoxifen therapy was carried out. No distant metastases and no local relapses were registered in the one year follow up. The Authors on the basis of their experience and according to the review of the Literature suggest that age itself is not a limiting factor to the therapeutic approach of ulcerated breast cancer.


Assuntos
Neoplasias da Mama/terapia , Carcinoma/terapia , Úlcera/terapia , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Antineoplásicos Hormonais/uso terapêutico , Neoplasias da Mama/radioterapia , Neoplasias da Mama/cirurgia , Carcinoma/radioterapia , Carcinoma/cirurgia , Terapia Combinada , Feminino , Seguimentos , Humanos , Retalhos Cirúrgicos , Tamoxifeno/uso terapêutico , Fatores de Tempo , Úlcera/radioterapia , Úlcera/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...